Generics - Antibiotics and Infectious diseases, Mylan Laboratories

Filter

Popular Filters

Mylan launches first generic of Pfizer antifungal

Mylan launches first generic of Pfizer antifungal

30-09-2013

Mylan says it has launched voriconazole for oral suspension, which is the first generic version of Pfizer's…

Antibiotics and Infectious diseasesGenericsMarkets & MarketingMylan LaboratoriesNorth AmericaPfizerVfend

Mylan debuts generic Antara; FDA approves generics of Actavis' Suboxone, Lupin's Suprax and Zydus' Zantac

25-02-2013

US generic firm Mylan (Nasdaq: MYL) says its subsidiary Mylan Pharmaceuticals has begun shipping fenofibrate…

ActavisAntaraAntibiotics and Infectious diseasesCardio-vascularGastro-intestinalsGenericsLupinMarkets & MarketingMylan LaboratoriesNeurologicalNorth AmericaRegulationSuboxoneSupraxZantacZydus Cadila

Teva settles Nuvigil patent litigation with Mylan, which debuts generic Doryx

01-05-2012

Israel-based Teva Pharmaceutical Industries (Nasdaq: TEVA), the world's largest generics companies, said…

Antibiotics and Infectious diseasesDoryxGenericsLegalMergers & AcquisitionsMylan LaboratoriesNeurologicalNorth AmericaNuvigilPatentsPharmaceuticalTeva Pharmaceutical IndustriesWarner Chilcott

COMPANY SPOTLIGHT

Parexel

Parexel

Back to top